AI assistant
Sending…
INSMED Inc — Director's Dealing 2018
Nov 2, 2018
30150_dirs_2018-11-02_8d01f4ef-51fe-4679-ad29-ad90d5a0c733.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2018-11-01
Reporting Person: Adsett Roger (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-01 | Common Stock | P | 3000 | $15.969 | Acquired | 18594 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $15.95 to $15.98. The prices reported above reflect the weighted average price. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.
More from INSMED Inc
Regulatory Filings
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Report Publication Announcement
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19